Literature DB >> 11694399

Immunosuppressive non-myeloablative allografting as salvage therapy in advanced Hodgkin's disease.

A M Carella, G Beltrami, M Carella, M T Corsetti, R P Scalzulli, M Greco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11694399

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  3 in total

1.  Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Almaguer; Jorge Vela-Ojeda; Amelia Morales-Toquero; Jóse David Gómez-Rangel; Miriam A García-Ruiz-Esparza; Briceida López-Martínez; Olga G Cantú-Rodríguez; César H Gutiérrez-Aguirrec
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 2.  Relapsed and refractory Hodgkin lymphoma: transplantation strategies and novel therapeutic options.

Authors:  Kevin A David; Lauren Mauro; Andrew M Evens
Journal:  Curr Treat Options Oncol       Date:  2007-10

3.  Unrelated donor reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.

Authors:  Marcel P Devetten; Parameswaran N Hari; Jeanette Carreras; Brent R Logan; Koen van Besien; Christopher N Bredeson; César O Freytes; Robert Peter Gale; John Gibson; Sergio A Giralt; Steven C Goldstein; Vikas Gupta; David I Marks; Richard T Maziarz; Julie M Vose; Hillard M Lazarus; Paolo Anderlini
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.